Navigation Links
Halt Uterine Fibroid Study Attracts National Media Attention
Date:2/1/2010

LIVERMORE, Calif., Feb. 1 /PRNewswire/ -- The Wall Street Journal, CBS, and other popular news outlets have recently featured headline stories about a clinical study that is recruiting patients suffering with uterine fibroids.  "We're not at all surprised by the attention this study is getting from the media," said Russ DeLonzor, President and Chief Operating Officer of Halt Medical, Inc., a medical technology company headquartered near San Francisco.  Fibroids are benign tumors of the uterus that cause serious, debilitating symptoms including heavy menstrual bleeding, severe cramping, urinary problems, and painful intercourse. Currently the only cure that the gynecologist can offer to patients with fibroids involves major surgery.  "Each year nearly 250,000 women in the US undergo radical surgery to remove their entire uterus rather than to continue suffering with their fibroid symptoms," according to Mr. DeLonzor.  About 8 million women have fibroids, or leiomyomas of the uterus.  "So many lives are impacted in some way by fibroids.  It's no surprise that a clinical study of an outpatient procedure which targets the fibroids while sparing the uterus would gain such widespread attention from the media."   Details of who may qualify for the Halt Uterine Fibroid Study and participating clinical sites are available through the National Institutes of Health at:  clinicaltrials.gov/ct2/show/NCT00874029

SOURCE Halt Medical, Inc.


'/>"/>
SOURCE Halt Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Gorilla Receives State-Of-The-Art Treatment for Uterine Fibroids from Interventional Radiologists
2. Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast, Ovarian, Uterine or Colorectal Cancer
3. Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists
4. UFE Highly Effective in Cases Where Focused Ultrasound to Treat Uterine Fibroids Failed
5. Major surgery no longer needed for the removal of uterine fibroids
6. Scientists ID Uterine Muscle Switch for Contractions
7. Black women with uterine cancers more likely to die than white patients
8. Gene Variant Raises Risk of Uterine Fibroids
9. Prominent Chicago Gynecologists Launch Treatment Project To Raise Awareness Among African American Women of Non-Invasive Ultrasound Uterine Fibroid Procedure
10. Singapore Premier Women's Hospital Offers Contactless Surgery for Uterine Fibroids
11. Chamberlain Group Announces New Uterine Robotic Surgery Training Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... Today American ... Wertheim College of Medicine announced the AUA-FIU Global MD Program. Students in ... Certificate from AUA and a Certificate of Completion from the FIU Herbert Wertheim ...
(Date:5/25/2016)... ... May 25, 2016 , ... CloudLIMS, joins an elite number of companies that ... Providers list of 2016 by CIOReview. , In a deliberate session with the honorary ... Providers 2016 has been concluded with. The positioning is based on evaluation of CloudLIMS’ ...
(Date:5/25/2016)... Livonia, MI (PRWEB) , ... May 25, 2016 , ... ... honors Allstate has to bestow: the Dick McKenna Good Hands Legacy Award. McKenna ran ... commitment to others which continues to inspire all those who knew him. The award ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... solutions to industries ranging from medical and pharmaceutical, to food and HVAC facilities. ... well as on-site training. , For medical applications, Afrimesure offers a variety ...
(Date:5/25/2016)... PA (PRWEB) , ... May 25, 2016 , ... ... announced the results of its annual Medical and Prescription Drug survey , ... benefits. , The survey, which was conducted in December 2015, indicates that ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Mass. , May 24, 2016  NxStage Medical, ... technology company focused on advancing renal care, today announced ... plans to participate in the following schedule of investor ... be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, June ...
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
(Date:5/24/2016)... 24, 2016 Open Access Journal ... Neurophysiology  Elsevier , a world-leading provider ... today announced the launch of Clinical Neurophysiology ... that focuses on clinical practice issues in clinical neurophysiology. ... series, normal values and didactic reviews. It is an ...
Breaking Medicine Technology: